Sign inJoin waitlistJoin the waitlist

Barbara Degar

Physician · Dana-Farber Cancer Institute

Credentials: · · · ·

History

Dana-Farber Cancer Institute
2025–Present

Pediatric Hematology Oncology
Yale Univ Sch of Med
1995–1998
Fred Hutchinson Cancer Research Center
1994–1995
Yale-New Haven Children's Hospital
1991–1994
New York University Grossman School of Medicine
1987–1991

Research

Recurrent BRAF mutations in Langerhans cell histiocytosis
Blood · 2010 · 921 citations
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
The Lancet Oncology · 2010 · 467 citations
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
New England Journal of Medicine · 2020 · 440 citations

Barrett Rollins
9 papers
LH
Lauren Henderson
8 papers
Ching-Hon Pui
7 papers
Christine Duncan
7 papers
Hiroto Inaba
7 papers
JR
Jeffrey Rubnitz
7 papers
Raul Ribeiro
7 papers
Jeffrey Taub
6 papers
Kimberly Davies
5 papers
LB
Leslie Benson
5 papers
Leslie Lehmann
5 papers
MG
Mark Gorman
5 papers

Clinical trials

Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders
Principal investigator · Active not recruiting · Phase 2
Dana-Farber Cancer Institute
2015–2026
International Rare Histiocytic Disorders Registry (IRHDR)
Site PI · Recruiting
The Hospital for Sick Children
2014–2028